Albion Financial Group UT acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,654 shares of the biotechnology company's stock, valued at approximately $2,389,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. State Street Corp raised its stake in Axon Enterprise by 5,700.2% in the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company's stock valued at $119,724,905,000 after purchasing an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of Axon Enterprise by 18,050.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company's stock valued at $7,400,094,000 after buying an additional 13,127,348 shares in the last quarter. BlackRock Inc. raised its position in shares of Axon Enterprise by 4.3% during the 2nd quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company's stock valued at $4,672,432,000 after buying an additional 345,365 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its position in shares of Axon Enterprise by 391,214.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company's stock valued at $2,952,943,000 after buying an additional 6,987,098 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Axon Enterprise by 8,432.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company's stock worth $1,983,414,000 after acquiring an additional 3,496,493 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts recently commented on AXON shares. UBS Group increased their target price on Axon Enterprise from $440.00 to $600.00 and gave the company a "neutral" rating in a research note on Thursday, August 6th. Citizens Jmp restated a "market outperform" rating and set a $700.00 price target on shares of Axon Enterprise in a research report on Thursday, June 25th. Needham & Company LLC reaffirmed a "buy" rating on shares of Axon Enterprise in a research note on Wednesday, September 2nd. Royal Bank Of Canada reaffirmed an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Finally, Citigroup reiterated a "market outperform" rating on shares of Axon Enterprise in a report on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of "Moderate Buy" and a consensus price target of $707.07.
Get Our Latest Analysis on AXON
Insider Buying and Selling at Axon Enterprise
In other Axon Enterprise news, insider Jeffrey Kunins sold 9,605 shares of the company's stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the sale, the insider directly owned 97,761 shares in the company, valued at $61,266,818.70. This represents a 8.95% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the company's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer owned 3,118,012 shares of the company's stock, valued at approximately $1,587,036,927.88. The trade was a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 47,397 shares of company stock valued at $26,722,984. Company insiders own 4.20% of the company's stock.
Key Headlines Impacting Axon Enterprise
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Axon outperformed the broader market in the latest session, continuing a short-term recovery after a substantial decline. The report highlights the stock’s relative strength but provides limited detail on a new fundamental catalyst. Why Axon Enterprise Outpaced the Stock Market Today
- Positive Sentiment: A proposed $22 million City of Reno technology deal could expand Axon’s police surveillance tools and provide evidence of continued demand from municipal customers, although the city council still needs to vote on the agreement. City of Reno Council to Vote on $22 Million Axon Deal
- Positive Sentiment: Commentary presents Axon as a differentiated way to invest in public-safety software, hardware and counter-drone technology. Another analysis argues that concerns weighing on the stock may be temporary, supporting a longer-term bullish view. Drone Stocks Have Burned Investors—Are These Four Different? Down 54%, This Tech Stock Looks Like a Buy With or Without AI
- Neutral Sentiment: A comparison with Arista Networks emphasizes Axon’s dominant public-safety ecosystem, but offers an investment-choice discussion rather than a new company-specific catalyst. Arista Networks vs. Axon Enterprise
- Negative Sentiment: Piper Sandler lowered its Axon price target substantially, though it retained an “overweight” rating. The cut signals greater caution around valuation or execution despite continued long-term optimism. Analyst Price Target Update
Axon Enterprise Trading Up 2.5%
AXON stock opened at $402.60 on Thursday. The company has a market capitalization of $32.71 billion, a PE ratio of 167.05, a price-to-earnings-growth ratio of 7.39 and a beta of 1.44. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $764.02. The company's 50 day moving average price is $488.51 and its two-hundred day moving average price is $474.26. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.84 by $0.04. The firm had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business's quarterly revenue was up 35.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.12 EPS. As a group, analysts predict that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.
Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.
The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.